#Endovascular Stent Graft Market in Spain

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[manideep8]

Abdominal Aortic Aneurysm Treatment Market Analysis - Forecast (2022 - 2027)

Abdominal Aortic Aneurysm Treatment Market size is estimated to reach $2.67 billion by 2027, growing at a CAGR of 5.82% during the forecast period 2022-2027. Abdominal aortic aneurysms are frequently discovered when a physical examination is performed for another reason or at the time of normal medical tests, like an ultrasound of the heart or abdomen. The objective of abdominal aortic aneurysm treatment is to avoid an aneurysm from breaking. Treatment may include cautious supervision or surgery. The kind of treatment adopted, relies on the size of the aortic aneurysm and how quickly it is developing. CT scan assesses the abdomen in more detail in patients with a particular abdominal grievance. It also evaluates the form of the aneurysm with more inclusive anatomical details of the mesenteric and iliac arteries, and also offers superior imaging of suprarenal aneurysms. Helical CT angiography can represent complexities that establish consequently to the treatment of abdominal aortic aneurysms with endovascular stent grafts. Long-term follow-up is needed to decide the complete spectrum and frequency of complexities that may establish after a favorable fix at the beginning. Conservation of spinal cord blood supply at the time of descending thoracic (TAA) and thoracoabdominal aortic aneurysm (TAAA) surgery is mandatory to avoid neurologic complexities. Investigations have been conducted to determine whether the preoperative and postoperative existence or absence of collateral arteries discovered by magnetic resonance angiography (MRA) is connected with spinal cord function at the time of the intraoperative exclusion of the segmental supply to the Adamkiewicz artery.

The increasing predominance of hypertension and hyperlipidemia is set to drive the Abdominal Aortic Aneurysm Treatment Market. The surging count of smokers with elderly male smokers requiring ultrasound screening along with pre-existing CT scans is set to propel the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027. This represents the Abdominal Aortic Aneurysm Treatment Industry Outlook.

Abdominal Aortic Aneurysm Treatment Market Report Coverage

The report: “Abdominal Aortic Aneurysm Treatment Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the  Abdominal Aortic Aneurysm Treatment Market.

By Treatment: Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR). By Product: Stent Graft, Catheter. By End Use: Hospital, Ambulatory Surgical Center, Others. By Geography: North America (U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Inquiry Before Buying : https://www.industryarc.com/reports/request-quote?id=15315

Key Takeaways

Geographically, North America Abdominal Aortic Aneurysm Treatment Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of abdominal aortic aneurysm requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm in the North American region.

Abdominal Aortic Aneurysm Treatment Market growth is being driven by the rising pervasiveness of abdominal aortic aneurysm globally requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm owing to altered lifestyle and the expanding population of the elderly. However, the cost and availability of treatment are some of the major factors hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.

Abdominal Aortic Aneurysm Treatment Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the   Abdominal Aortic Aneurysm Treatment Market report.

Request For Sample : https://www.industryarc.com/pdfdownload.php?id=15315

Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Treatment:

The Abdominal Aortic Aneurysm Treatment Market based on treatment can be further segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). The Endovascular Aneurysm Repair (EVAR) Segment held the largest market share in 2021. This growth is owing to the enhanced patient survival offered by the Endovascular Aneurysm Repair technique. Endovascular repair (EVAR) is the positioning of a stent graft (fabric-covered tube) into the aneurysm by way of a tiny hole in the blood vessels in the groin. CT scan has been performed consequent to Endovascular Repair of Abdominal Aortic Aneurysms. The heightened demand for minimally invasive processes owing to minimized hospital stays and patient trauma in conjunction with the soaring success rate provided by technologically progressive devices is further propelling the growth of the Endovascular Aneurysm Repair (EVAR) segment.

Furthermore, the Open Surgical Repair (OSR) segment is estimated to grow with the fastest CAGR of 6.5% during the forecast period 2022-2027 owing to the superior outcomes of open surgical repair (OSR) in comparison with endovascular aneurysm repair (EVAR) for infrarenal abdominal aortic aneurysm (IRAAA) as per results of a retrospective cohort investigation issued in the Journal Vascular Brasileiro and CT scan is recommended with or without contrast at 5-year intervals after open surgical repair for thoracic aortic disease.

Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Product:

The Abdominal Aortic Aneurysm Treatment Market based on the product can be further segmented into Stent Graft and Catheter. The Stent Graft Segment held the largest market share in 2021. This growth is owing to the surging application of stent-grafts in Abdominal Aortic Aneurysm Treatment. Nellix and Ovation stent-grafts are novel generation prostheses that use polymer technology to treat abdominal aortic aneurysms. CT scan can be performed postoperatively. The benefits of endovascular repair with stent-graft are further propelling the growth of this segment.

Furthermore, the Catheter segment is estimated to grow with the fastest CAGR of 6.7% during the forecast period 2022-2027 owing to the surging application of Catheter-based aortic aneurysm repair attributed to it being a safe and preferred option of treatment for numerous patients with aortic aneurysms and investigations being conducted for intra-arterial catheter=directed CT angiography for evaluation of endovascular aortic aneurysm repair.

Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Geography:

The Abdominal Aortic Aneurysm Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Abdominal Aortic Aneurysm Treatment Market) held the largest share with 39% of the overall market in 2021. The growth of this region is owing to the increasing predominance of abdominal aortic aneurysms in the region. The continued technological upgrades in the healthcare sector and the increasing predominance of cardiovascular diseases requiring CT scans are further driving the growth of the Abdominal Aortic Aneurysm Treatment Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like expanding population of the elderly being more susceptible to incessant ailments requiring the application of CT scans in the Asia-Pacific region. The supportive government policies increased spending on healthcare, and proliferating modernization of medical infrastructure are further fuelling the progress of the   Abdominal Aortic Aneurysm Treatment Market in the Asia-Pacific region.

Abdominal Aortic Aneurysm Treatment Market Drivers

Surging Applications Of Abdominal Computed Tomography Angiography Are Projected To Drive The Growth Of   Abdominal Aortic Aneurysm Treatment Market:

Computed tomography angiography (CTA) transformed vascular imaging when vessels tinier than 1 mm in diameter were imaged with single-slice spiral CT. Other than its restricted invasiveness, the benefits of CT Angiography involve reduced cost and a possible minimization in the total volume of contrast material administered. With the quickest scanners presently accessible (16, 64, 256 slices), abdominal Computed Tomography Angiography may be carried out with as little as 50 mL of contrast material utilizing a saline flush. Typical abdominal uses of CTA involve assessment of the abdominal aorta, preoperative and postoperative evaluation for renal and liver transplantation, preoperative planning for hepatic segmentectomy and pancreatic surgery, mesenteric ischemia, and gastrointestinal (GI) hemorrhage. Additional uses involve cholecystectomy and splenectomy planning, and evaluation for renal arterial disease in the assessment of hypertension. The protocols for every use should be separately tailor-made to optimize imaging of the targeted vascular structures. CTA is typically the approved imaging modality for the assessment of the abdominal aorta in intense and non-emergent settings. The surging applications of abdominal computed tomography angiography are therefore fuelling the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.

Heightened Applications Of Magnetic Resonance Angiography For The Treatment of Infrarenal Abdominal Aortic Aneurysms Are Expected To Boost The Demand Of Abdominal Aortic Aneurysm Treatment Market:

Magnetic resonance angiography (MRA) like Computed Tomography Angiography (CTA) has the advantage of being able to envision the complete aorta inclusive of its branch vessels. Dissimilar to CTA, it does not reveal the patient to radiation nor is iodinated contrast dye needed. This can be more attractive for patients with a contrast allergy or renal inadequacy. In patients with kidney ailments, non-gadolinium contrast agents prevail. Blood pool contrast agents, like ferumoxytol, may be utilized to improve MRA to offer good imaging quality. Additionally, typical investigations have discovered that non-contrast magnetic resonance imaging (MRI), when teamed with electrocardiographic- and cardiac-gated methods, has identical image quality in comparison with contrast-enhanced MRA images of the aorta. Time-resolved 3D phase-contrast MRI with three-directional velocity encoding, also termed as 4D flow MRI has currently emerged as an instrument to more thoroughly assess abdominal circulation. 4D flow MRI may permit for more precise aortic modeling in the future owing to its capability to concurrently assess vascular anatomy and hemodynamics. MRA is commensurate to CTA with respect to the precision of AAA assessments. The heightened applications of Magnetic Resonance Angiography for the treatment of Infrarenal Abdominal Aortic Aneurysms are driving the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.

Abdominal Aortic Aneurysm Treatment Market Challenges

Handling Of The Ruptured Abdominal Aortic Aneurysm By Paramedics Poses Challenges To The Growth Of The Abdominal Aortic Aneurysm Treatment Market:

The ruptured abdominal aortic aneurysm is a time-critical medical emergency needing timely surgical intervention to provide any opportunity of survival. Even when identified early, 90% of patients will endure an out-of-hospital cardiac arrest prior to landing at the emergency department and of those who arrive at the theatre, only 40% will survive. The ruptured AAA needs urgent surgical intervention. These kinds of patients cannot be stabilized in the prehospital environment and endeavors to do so will be pointless and are likely to jeopardize patient care. The paramedic practitioners handling of the ruptured AAA must involve, and sometimes be restricted to, accelerated identification and practical transport to a hospital with competence in handling vascular emergencies. Intravascular access must not defer transport to a suitable receiving facility. Prehospital interventions like fluid administration can minimize the occurrence of post-operative complexities like acute renal failure. However, this should not be utilized to legitimize numerous cannulation efforts on the scene. The establishment of a fast-track pathway for direct admission to theatre could possibly save lives. Further research and the establishment of such a pathway should include all members of the multi-disciplinary team. These issues are hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.

Buy Now : https://www.industryarc.com/purchasereport.php?id=15315

Abdominal Aortic Aneurysm Treatment Market - Landscape:

Product launches, mergers and acquisitions, joint ventures, and R&D Activities are key strategies adopted by players in the   Abdominal Aortic Aneurysm Treatment Market. Key companies of this market are:

Novartis Pharmaceuticals

Merck

Cook Medical Inc.

Endologix Inc.

W.L.Gore & Associates

Medtronic Plc.

Cardinal Health Inc.

Lombard Medical, Inc.

Terumo Aortic

Cardiatis S.A.

Recent Developments

In April 2021, Cardinal Health introduced Outcomes™, a digital ecosystem linking pharmacists, payers, and pharmaceutical firms to diminish the challenges of medicine non-adherence. Outcomes convey digital health solutions for personalized medication therapy administration, digital patient engagement, and tele pharmacy, through its Connect™ platform. Therefore, these three customer groups can enhance patient adherence to medicine, fuel superior health outcomes for patients, and reduce the cost of care.

In July 2020, Novartis declared a novel initiative to assist patients in low-income and lower-middle-income countries (LIC; LMIC) access economical medications to treat the principal symptoms of COVID-19 – a crucial requirement in the absence of a vaccine or curative treatment. Inflammation and respiratory issues connected with COVID-19 may bring about serious medical complexities and may result in demise in certain people, establishing an enormous burden on delicate healthcare systems. The Novartis COVID-19 portfolio involves 15 medications from its Sandoz division for gastrointestinal sickness, intense respiratory symptoms, pneumonia, and septic shock.

In March 2020, Endologix® Inc. declared that it has accepted an endorsement from the U.S. Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto). The firm accepted endorsement based on its supervisory compliance that involves the ELEVATE Investigational Device Exemption (IDE) clinical investigation. Agreeable to the terms of endorsement, the earliest 100 patients consequent to commercial introduction will be involved in a post-approval imaging study to decide constancy in instrument choice between Endologix’s internal imaging services and those of the implanting physicians.

Related Reports-

Endovascular Abdominal Aortic Aneurysm Repair Devices Market

Report Code: HCR 46793

Aortic Aneurysm Market

Report Code: HCR 81184

For more Lifescience and Healthcare related reports, please

click here

[healthcaredbmrnews]

Data Bridge Market Research analyses that the vascular grafts and peripheral stents market will project a CAGR of 6.34% for the forecast period of 2021-2028.

[marketresearchlatestreports]

Branched Stent Grafts Market: Key Players to Gain Competitive Advantage

The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.

ResearchMoz report delivers an in-depth analysis of the global stent grafts interface marketplace, including its size, key drivers for growth, major opportunities and challenges it faces along with the regional segments that will experience significant expansion over time.

Polymer-Based Technology to Drive the Branched Stent Grafts Market

Recently, polymer-based technologies have been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin neoprene-based neck sealing device that’s also called the Ovation stent graft. EVAS was not successful despite being in use for some time now but EVAR has established itself as safe and effective; leading to the expansion of the global branched stents market.

Growing Vascular Surgeries Boost Demand

The growing number of vascular surgeries are driving the global branched stent grafts market and will continue during the forecast period. This is primarily due to the growing geriatric population across the globe and growing cases of coronary heart diseases.

However, the poor durability of metallic grafts will impede the growth during the forecast period.

Nonetheless, the rising demand for biocompatible stents will allow the market to grow exponentially in the coming years.

The players in the global branched stent-grafts market include-

Abbott

Cook Medical

Eucatech AG

Merit Medical Systems

Endocor GmbH

Boston Scientific Corp.

Terumo Corp.

Medtronic

Biotronik

Alvimedica

Cardinal Health (Cordis)

Read More: https://www.beetribune.com/branched-stent-grafts-market-survey-report/

Key takeaways

ReseachMoz shares detailed insights on the branched stent grafts market, which will help the stakeholders to be informed and take thoughtful decisions to thrive in this space. Some of the key takeaways from the report.

The global branched stent grafts market will exhibit growth at 8.0% CAGR between 2021 to 2028.

The increasing prevalence of coronary artery diseases and the rising number of geriatric populations are driving this market.

Asia-Pacific holds a promising future as well for branched stent grafts due to its high incidence rates of coronary heart diseases. While North America will dominate the global branched stent market in the coming years.

Regional Outlook

 North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Russia

Greece

The Netherlands

Asia Pacific

Japan

China

India

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Download Report PDF: Branched Stent Grafts Market

[metiresearchinfo]

Peripheral Vascular Devices Market : Meticulous Research® Reveals Why this Market is Growing at a CAGR of 6.9% to Reach 12.02 Billion by 2028

In its latest publication on the peripheral vascular devices market, Meticulous Research® analyses that the market is expected to grow at a CAGR of 6.9% from 2021 to 2028 to reach $12.02 billion. The increasing prevalence of peripheral vascular diseases associated with obesity, diabetes, and hypertension; growing geriatric population; increasing demand for minimally invasive treatment options; and increasing prevalence of disease-causing lifestyles are the major factors driving the growth of this market.

To provide efficient analysis, Meticulous Research has segmented this market based on type [angioplasty balloons (old/normal balloons, drug-eluting balloons, cutting & scoring balloons);  angioplasty stents (drug-eluting stents, bare-metal stents (expandable balloon stents, self-expandable stents)); catheters (angiography catheters, guiding catheters, IVUS/OCT catheters); endovascular aneurysm repair stent grafts (abdominal aortic aneurysm stent-grafts, thoracic aortic aneurysm stent grafts); inferior vena cava filters (retrievable filters, permanent filters); plaque modification devices (atherectomy devices, thrombectomy devices); hemodynamic flow alteration devices (embolic protection devices, chronic total occlusion devices); and other devices] and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

Download Sample Report Now : https://www.meticulousresearch.com/download-sample-report/cp_id=5180

Based on type, the peripheral vascular devices market is segmented into angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other types. In 2020, the angioplasty stents segment accounted for the largest share of the peripheral vascular devices market. Factors driving the growth of this segment include reduced restenosis rate associated with these products and their benefits, such as smaller incisions, faster recovery time, and lower risk of complications.

Based on geography, this research report analyzes and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2020, North America dominated the peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; increasing number of obese & diabetic population; and the presence of key players are driving the growth of this regional segment.

Speak to our Analysts to Understand the In Detail Impact of COVID-19 on Your Business:  https://www.meticulousresearch.com/speak-to-analyst/cp_id=5180

The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, market share analysis, and geographical presence on some of the key players in this market, including Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), BIOTRONIK SE & Co. KG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Edwards Lifesciences Corporation (U.S.), iVascular (Spain), Koninklijke Philips N.V. (Netherlands), Medtronic Public Limited Company (Ireland), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), and Terumo Corporation (Japan).

You can buy report here : https://www.meticulousresearch.com/Checkout/12322365

Contact: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[unabashedcollectivepizza]

Aortic Stents Grafts Market Size, Opportunities, Analysis and Forecast to 2028

Aortic Stents Grafts Market size was  Bn in 2019 and is expected to reach  Bn by 2027, at a CAGR of  during forecast period.

Aortic Stents Grafts Market Overview:

The study covers the Aortic Stents Grafts market's most recent revenue and market trends. It stresses a market overview, definition, and structure, as well as preventative and pre-planned management. The report focuses on the factors that influence the Aortic Stents Grafts Market, such as gross margin, cost, market share, capacity utilisation, and supply. It also aids in determining the future potential of Aortic Stents Grafts Market in the next years. The report presents a market overview through common subjects that are highlighted with unique data based on the need. This overview aids in making decisions about how to approach the market and comprehending the industry's backdrop.

Request for free sample:

https://www.maximizemarketresearch.com/request-sample/89372

Market Scope:

Key Market Trends & Challenges:

The study analyses the primary adoption trend impacting the Aortic Stents Grafts industry as well as issues that may stymie its expansion. Understanding these elements is critical for product planning and design, as well as commercial strategies. To assist you understand the Aortic Stents Grafts market, this study provides a full analysis of these trends and obstacles.

Market Statistics:

The report provides the market size and share of the Aortic Stents Grafts market. It helps in understanding the market and the report estimates upfront data and statistics that make the report a very valuable guide for individuals dealing with advertising and industry decision-making processes in the Aortic Stents Grafts market.

Get more Report Details

https://www.maximizemarketresearch.com/market-report/global-stent-grafts-market/89372/

Segmentation:

An aortic stent graft is a device used for the treatment of an aneurysm. It is also known as endovascular stent graft (EVAR). This treatment involves an artificial stent graft, delivered through an arterial blood vessel in the groin, fixed over the widening. These are used for abdominal and thoracic aortic aneurysm endovascular repair.

Key Players:

• Becton, Dickinson and Company • MicroPort Scientific Corporation Inc. • Medtronic Plc. • W.L. Gore & Associates • Cardinal Health Inc. • Terumo Corporation Inc. • Bolton Medical • Cardinal Health

Regional Analysis:

Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Aortic Stents Grafts market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa.

COVID-19 Impact Analysis on Aortic Stents Grafts Market:

The report has identified detailed impact of COVID-19 on Aortic Stents Grafts market in regions such as North America, Asia Pacific, Middle-East, Europe, and South America. The report provides Comprehensive analysis on alternatives, difficult conditions, and difficult scenarios of Aortic Stents Grafts market during this crisis. The report briefly elaborates the advantages as well as the difficulties in terms of finance and market growth attained during the COVID-19. In addition, report offers a set of concepts, which is expected to aid readers in deciding and planning a strategy for their business.

Key Questions answered in the Aortic Stents Grafts Market Report are:

Which product segment grabbed the largest share in the Aortic Stents Grafts market?

How is the competitive scenario of the Aortic Stents Grafts market?

Which are the key factors aiding the Aortic Stents Grafts market growth?

Which region holds the maximum share in the Aortic Stents Grafts market?

What will be the CAGR of the Aortic Stents Grafts market during the forecast period?

Which application segment emerged as the leading segment in the Aortic Stents Grafts market?

Which are the prominent players in the Aortic Stents Grafts market?

What key trends are likely to emerge in the Aortic Stents Grafts market in the coming years?

What will be the Aortic Stents Grafts market size by 2027?

Which company held the largest share in the Aortic Stents Grafts market?

About Us:

Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.

Contact Us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT Park Phase 2,

Pune Bangalore Highway,

Narhe, Pune, Maharashtra 411041, India.

Email: sales@maximizemarketresearch.com

Phone No.: +91 20 6630 3320

Website: www.maximizemarketresearch.com

Related report link: http://www.marketwatch.com/story/ride-sharing-market-top-manufacturers-sales-revenue-trends-size-top-leaders-future-scope-and-forecast-to-2027-2022-01-14

[itssashasharma]

Peripheral Vascular Devices Market worth $13.4 billion by 2026, at a CAGR of 5.3%

According to the new market research report "Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 13.4 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. Browse in-depth TOC on "Peripheral Vascular Devices Market" 499 – Tables 43 – Figures 347 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790 The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption. Hemodynamic flow alteration devices in the product segment to witness the highest growth during the forecast period. Based on the product, the peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Embolic Protection Devices segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are increasing investments in new technology development and the growing number of regulatory approvals for these devices, and venture capital funding for the development of advanced EPDs. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=790 North America dominates the global peripheral vascular devices market. The peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America accounted for the largest share of the market. The large share of North America can be attributed to the growth in the geriatric population and the high prevalence of peripheral vascular diseases. Furthermore, the presence of key market players in this region ensures high access to medical devices The major players in the peripheral vascular devices market Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany).

[adityarana1687-blog]

Vascular Grafts Market Assures To Achieve $3.30 Billion By 2026

The global vascular grafts market size is projected to reach at USD 3.30 billion by 2026 expanding at a CAGR of 6.4%, according to a report by Grand View Research, Inc. Endovascular stent grafts dominated the market in 2018 and is expected to be the second fastest-growing segment over the forecast period. Increasing prevalence of cardiovascular aneurysms is the leading cause of rise in demand for endovascular stent grafts. Low levels of physical activity, sedentary lifestyle, and substance abuse are some of the key factors leading to the high prevalence of renal and Cardiac Diseases (CVDs) globally. The impact of these factors is especially high in developed economies, such as North America and Europe. However, it is expected to shift towards emerging regions, such as Asia Pacific and Latin America, owing to changing demographics.

Key factors attributed to higher impact in these countries are increasing prevalence of aforementioned diseases in geriatric population, rising disposable income, and changing lifestyle patterns. Polytetrafluoroethylene (PTFE) raw material segment led the global market in 2018 with a revenue of USD 710.3 million. The segment is anticipated to expand at the fastest CAGR over the forecast period on account of PTFE graft’s advantages, such as protection against delamination and minimal blood loss. Asia Pacific is expected to be the fastest-growing market with a CAGR of 7.5% over the forecast period due to increasing public and private healthcare expenditure and availability of healthcare insurance across urban and rural centers.

Request a free sample copy or view report summary: CVascular Grafts Market Report

Vascular Grafts Market Report Highlights

Endovascular stent grafts led the market in 2018 as a result of increased prevalence of cardiac aneurysms caused due to sedentary lifestyle and other occupational factors

PTFE grafts led the raw materials segment in 2018 owing to their advantages, such as minimal blood loss and maximum protection against delamination

Moreover, technological advancements in PTFE-based products is anticipated to drive the segment further

North America was the dominant regional market with a revenue of USD 620.9 million owing to high prevalence of CVDs and kidney diseases

The region is projected to maintain the dominance in future due to the presence of advanced healthcare facilities and reimbursement policies

Some of the key companies in this market include Medtronic, plc; LeMaitre Vascular Inc.; Terumo Corp.; Getinge AB; W.L. Gore and Associates, Inc.; and Cook Medical, Inc.

These companies focus on technological innovations, new product launches, and regional expansion to gain a competitive edge

Vascular Grafts Market Segmentation

Grand View Research has segmented the global vascular grafts market on the basis of product, application, raw material, and region:

Vascular Grafts Product Outlook (Revenue, USD Million, 2014 - 2026)

Hemodialysis Access

Endovascular Stent

Peripheral

Vascular Grafts Application Outlook (Revenue, USD Million, 2014 - 2026)

Cardiac Aneurysms

Kidney Failure

Vascular Occlusion

Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2014 - 2026)

Polyester-based

Polytetrafluoroethylene-based

Polyurethane based

Biological Materials-based

Human Saphenous and Umbilical Veins

Tissue Engineered Materials

Vascular Grafts Regional Outlook (Revenue, USD Million, 2014 - 2026)

North America

Europe

Asia Pacific

Latin America

MEA

U.S.

Canada

U.K.

Germany

Spain

France

Italy

Russia

China

Japan

India

South Korea

Singapore

Australia

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[crystalmarketresearch]

Interventional Cardiology & Peripheral Vascular Devices Market To Register Substantial Expansion By 2023

A research study titled, “Interventional Cardiology & Peripheral Vascular Devices Market by product (angioplasty stents, angioplasty balloon catheter, guidewires, vascular closure devices, peripheral embolic protection devices, atherectomy devices, endovascular stent grafts, vascular grafts, thrombectomy devices, inferior vena cava filter, other products) - global industry analysis and forecast to 2023” published by crystal market research. Competitive Outlook-  The leading players in the market are B. Braun Melsungen AG, Cardinal Health, Inc., Medtronic plc, Terumo Corporation, ABIOMED, Inc. and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Get sample copy of this report:  www.crystalmarketresearch.com/report-sample/HC071100 Industry Outlook- The Interventional Cardiology & Peripheral Vascular Devices Market was worth USD 12.18 billion in 2014 and is expected to reach approximately USD 27.82 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.61% during the forecast period.  Cardiovascular diseases is one of the essential driver of the worldwide mortality was in charge of 17.7 million passing’s around the world, as announced by the World Health Organization (WHO). This worldwide rate of death raised the significance of taking preventive wellbeing measures and cantering into advancement of enhanced treatment devices keeping in mind the end goal to accomplish powerful clinical results. Interventional method deployment in cardiology and fringe vascular ailment treatment is generally liked to stay away from entanglements and scar, diminishing torment and quicker recuperation. Market Segmentation- Interventional Cardiology & Peripheral Vascular Devices Market By Product Angioplasty Stents Angioplasty Balloon Catheter Guidewires Vascular Closure Devices Peripheral Embolic Protection Devices Atherectomy Devices Endovascular Stent Grafts Vascular Grafts Thrombectomy Devices Inferior Vena Cava Filter Interventional Cardiology & Peripheral Vascular Devices Market - By Region: Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) North America (U.S, Canada, Mexico) Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) Rest of the World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others) Drivers & Restrains Continuous mechanical developments in the field of interventional cardiology and fringe vascular gadgets are relied upon to drive the worldwide market. Researchers have concentrated on growing new frameworks with enhanced traits, for example, new age of medication eluting inflatables, and bio absorbable stents. Likewise, a few organizations have put resources into their research and development exercises to create imaginative products. Awareness among patients about coronary heart sicknesses and fringe vascular scatters assumes an imperative part in market development. Regional Outlook -  Over the previous decade, legislatures of different nations, particularly rising economies, have expanded their consumption on building up their human services framework. In this manner, increment in broad daylight and private use to build up the wellbeing framework in these locales will additionally support the selection of interventional cardiology and peripheral vascular devices in creating nations. Research Methodology We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments. To Avail Discount, Please click On the Link @ www.crystalmarketresearch.com/check-discount/HC071100 About Crystal Market Research: Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy. Contact Us: Judy S,  304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: +1-888-213-4282 Email: Sales@Crystalmarketresearch.Com

[manideep8]

Aortic Intervention Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2022 - 2027

Aortic Intervention Market size is estimated to reach $3.4 billion by 2027, growing at a CAGR of 6.7% during the forecast period 2022-2027. Aortic intervention includes mending of aortic valve walls when an aneurysm happens. There has been immense progress in the endovascular treatment of aortic pathologies. Intra-renal abdominal aortic aneurysms can be treated by endovascular graft in most cases and endovascular aortic repair has acquired expansive acceptance all through the world. The abdominal aorta is the biggest artery in the abdominal cavity. As a portion of the aorta, it is a direct extension of the descending aorta (of the thorax). The thoracic aorta starts at the heart, at the level of the aortic valves. The thoracic aorta evolves into the abdominal aorta at the diaphragm, just bordering the celiac artery origin, normally at the T12 vertebral body.

Report Coverage

The report : “Aortic Intervention Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Aortic Intervention Market.

By Device Type : Abdominal Aortic Stent Grafts. Thoracic Aortic Stent Grafts, Fenestrated Aortic Stent Grafts, Others. By End User : Hospitals, Clinics, Others. By Geography : North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

[healthcaredbmrnews]

Aortic repair devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 5.45% in the above-mentioned forecast period. Increase in the numbers of endovascular procedures drives the aortic repair devices market.

[marketresearchlatestreports]

Branched Stent Grafts Market to Reflect Impressive Growth Rate

The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.

ResearchMoz report delivers an in-depth analysis of the global stent grafts interface marketplace, including its size, key drivers for growth, major opportunities and challenges it faces along with the regional segments that will experience significant expansion over time.

Polymer-Based Technology to Drive the Branched Stent Grafts Market

Recently, polymer-based technologies have been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin neoprene-based neck sealing device that’s also called the Ovation stent graft. EVAS was not successful despite being in use for some time now but EVAR has established itself as safe and effective; leading to the expansion of the global branched stents market.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/request-free-sample/?reportid=1453

Growing Vascular Surgeries Boost Demand

The growing number of vascular surgeries are driving the global branched stent grafts market and will continue during the forecast period. This is primarily due to the growing geriatric population across the globe and growing cases of coronary heart diseases.

However, the poor durability of metallic grafts will impede the growth during the forecast period.

Nonetheless, the rising demand for biocompatible stents will allow the market to grow exponentially in the coming years.

The players in the global branched stent-grafts market include-

Abbott

Cook Medical

Eucatech AG

Merit Medical Systems

Endocor GmbH

Boston Scientific Corp.

Terumo Corp.

Medtronic

Biotronik

Alvimedica

Cardinal Health (Cordis)

Key takeaways

ReseachMoz shares detailed insights on the branched stent grafts market, which will help the stakeholders to be informed and take thoughtful decisions to thrive in this space. Some of the key takeaways from the report.

The global branched stent grafts market will exhibit growth at 8.0% CAGR between 2021 to 2028.

The increasing prevalence of coronary artery diseases and the rising number of geriatric populations are driving this market.

Asia-Pacific holds a promising future as well for branched stent grafts due to its high incidence rates of coronary heart diseases. While North America will dominate the global branched stent market in the coming years.

Inquire More About This Report: https://www.researchmoz.us/enquiry-before-buying/?reportid=1453

Regional Outlook

North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Russia

Greece

The Netherlands

Asia Pacific

Japan

China

India

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Download Report PDF: Branched Stent Grafts Market

Have a Look at Other Research Reports:

Aerospace Lubricant Market - https://www.beetribune.com/aerospace-lubricant-market-forecast/

Plant-based Milk Market - https://www.beetribune.com/plant-based-milk-market-revenue/

Adhesive Equipment Market - https://www.beetribune.com/adhesive-equipment-market-growth/

Adaptive Optics Market - https://www.beetribune.com/the-global-adaptive-optics-market-forecast/

Active Electronic Components Market - https://www.beetribune.com/the-global-active-electronic-components-market-research-report/

Acoustic Diaphragm Market - https://www.beetribune.com/acoustic-diaphragm-market-outlook/

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz Abhishek Budholiya Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us Follow us on LinkedIn: https://www.linkedin.com/company/researchmoz Follow us on Twitter: https://twitter.com/researchmoz Media Release: https://www.researchmoz.us/pressrelease

[theshadowytastemakerstuden-blog1]

Aortic Stents Grafts Market : Know The Key Growth Drivers Developments and Innovations

The primary objective of the report is to offer updates and information related to market opportunities in the global aortic stent grafts market.

Report Description

In terms of revenue, the global aortic stent grafts market is expected to register a CAGR of 7.6% during the forecast period of 20182028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global aortic stent grafts market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global aortic stent grafts market are presented in the report.

The global demand for aortic stent grafts is increasing as a result of rising life expectancy and increasing prevalence of aneurysm. Merger & acquisition activities among manufacturers, launch of bifurcated and fenestrated aortic stent grafts, adoption of new surgical techniques are expected to spur the demand for aortic stent grafts. Besides, increase in global healthcare expenditure, adoption of minimally invasive surgeries, favorable reimbursement policies for endovascular repair surgeries are the other factors also expected to boost the aortic stent grafts market growth.

To Download Sample Report With TOC:  https://www.researchmoz.us/enquiry.php?type=S&repid=1877978

The revenue of the aortic stent grafts market in Japan is expected to grow at a high rate due to growing adoption of EVAR procedures and favourable reimbursement policies. To understand and assess opportunities in this market, the report offers the market forecast on the basis of product type and end users. The report provides analysis on the global aortic stent grafts market in terms of market value (US$ Mn).

The report begins with the market definition, followed by definitions of the different aortic stent grafts types. The market dynamics section includes FMIs analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global aortic stent grafts market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights

Read Comprehensive Overview of Report @  https://www.researchmoz.us/aortic-stents-grafts-market-increasing-demand-for-abdominal-aortic-stent-graft-to-be-witnessed-in-the-coming-years-global-industry-analysis-2013-2017-and-opportunity-assessment-2018-2028-report.html

The subsequent section of the report provides analysis of market on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:

North America

U.S.

Canada

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Western Europe

Germany

Italy

France

Spain

K.

Rest of Western Europe

Eastern Europe

Russia

Poland

Rest of Eastern Europe

Asia Pacific Excluding Japan

India

China

ASEAN

Australia & New Zealand

Rest of APEJ

Japan

Middle East & Africa (MEA)

GCC Countries

South Africa

Rest of MEA

The next section provides competitive edge of the global aortic stent grafts market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the aortic stent grafts market. The competition landscape section provides dashboard view of the activities of major players in the global aortic stent grafts market. The company profile section provides information on the key offerings of each player in the global aortic stent grafts market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis. The key players included in this report are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and Lombard Medical Inc..

Make An Enquiry@  https://www.researchmoz.us/enquiry.php?type=E&repid=1877978

The next section analyses the market on the basis of product type and presents forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:

Abdominal Aortic Stent Graft

Thoracic Aortic Stent Graft

The next section analyses the market on the basis of the end users and presents forecast in terms of value (US$ Mn) for the next 10 years. The end users covered in the report include:

Hospitals

Ambulatory Surgical Centers/Outpatient Surgical Centers

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global aortic stent grafts market.

Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by aortic stent grafts market. To understand the key segments in terms of their growth and performance in the global aortic stent grafts market, Future Market Insights has developed a market attractiveness index. The resulting index will help providers to identify the existing market opportunities.

About ResearchMoz ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact: ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Website: https://www.researchmoz.us Email: sales@researchmoz.us Follow us on LinkedIn @ http://bit.ly/1TBmnVG Blog: https://researchknowledgeresource.blogspot.com/

[kbvresearch]

Latest release published on KBV Research News

Latest press release on:

Vascular Graft Market to reach a market size of $6 billion by 2023

According to a new report Global Vascular Graft Market, published by KBV research, the Vascular Graft Market Size was valued at $4 billion in 2016, and is estimated to reach $6 billion by 2023, growing at a CAGR of 6% during the forecast period

The North America market held the largest share in the Global Vascular Graft Market by Region in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 5.4 % during the forecast period. Additionally, The Asia Pacific market is expected to witness a CAGR of 7.6% during (2017 – 2023).

The Endovascular Aneurysm Repair Stent Grafts market held the largest share in the Global Vascular Graft Market by Product in 2016, and would continue to be a dominant market till 2023. The Thoracic Aortic Aneurysm (TAA) market is expected to witness a CAGR of 7% during (2017 – 2023).

The Hospitals market held the largest share in the Global Vascular Graft Market by End User in 2016, and would continue to be a dominant market till 2023 growing at a CAGR of 5.1 % during the forecast period.

The Polytetrafluoroethylene (PTFE) market dominated the Canada Vascular Graft Market by Raw Material in 2016, and would continue to be a dominant market till 2023. The Biosynthetic market is expected to witness a CAGR of 10.5% during (2017 – 2023).

Full Report: https://kbvresearch.com/vascular-graft-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the Global Vascular Graft Market have been discussed in the report with the elaborated company profiles are B. Braun Melsungen AG, C. R. Bard, Inc., Cardinal Health Inc., Medtronic, Endologix Inc., Cook Medical Inc., LeMaitre Vascular, Inc., Terumo Corporation, W. L. Gore & Associates, Inc., and Getinge AB.

Global Vascular Graft Market Size Segmentation

By Product

Endovascular Aneurysm Repair Stent Grafts

Abdominal Aortic Aneurysm (AAA)

Thoracic Aortic Aneurysm (TAA)

Hemodialysis Access Graft

Peripheral vascular graft

By Raw Material

Polytetrafluoroethylene (PTFE)

Biosynthetic

Polyester

Polyurethane (PU)

By End User

Hospitals

Ambulatory Surgical Centers

By Geography

North America Vascular Graft Market Size

US Vascular Graft Market Size

Canada Vascular Graft Market Size

Mexico Vascular Graft Market Size

Other NA Country Vascular Graft Market Size

Europe Vascular Graft Market

Germany Vascular Graft Market

UK Vascular Graft Market

France Vascular Graft Market

Russia Vascular Graft Market

Spain Vascular Graft Market

Italy Vascular Graft Market

Other EU Country Vascular Graft Market

Asia Pacific Vascular Graft Market

China Vascular Graft Market

Japan Vascular Graft Market

India Vascular Graft Market

South Korea Vascular Graft Market

Singapore Vascular Graft Market

Malaysia Vascular Graft Market

Other APAC Country Vascular Graft Market

Latin America, Middle East and Africa (LAMEA) Vascular Graft Market

Brazil Vascular Graft Market

Argentina Vascular Graft Market

UAE Vascular Graft Market

Saudi Arabia Vascular Graft Market

South Africa Vascular Graft Market

Nigeria Vascular Graft Market

Other LAMEA Country Vascular Graft Market

Companies Profiled

Braun Melsungen AG

R. Bard, Inc.

Cardinal Health Inc.

Medtronic

Endologix Inc.

Cook Medical Inc.

LeMaitre Vascular, Inc.

Terumo Corporation

L. Gore & Associates, Inc.

Getinge AB

Unique Offerings from KBV Research

Exhaustive coverage of Global Vascular Graft Market

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

Related Reports:

North America Vascular Graft Market (2017-2023)

Europe Vascular Graft Market (2017-2023)

Asia Pacific Vascular Graft Market (2017-2023)

LAMEA Vascular Graft Market (2017-2023)

[healthcaredbmrnews]

Aortic repair devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 5.45% in the above-mentioned forecast period. Increase in the numbers of endovascular procedures drives the aortic repair devices market.